Fund profile
Tickers
CNCR
Fund manager
Total assets
$19.40 mm
Liabilities
$10.62 k
Net assets
$19.39 mm
Number of holdings
81.00
CNCR stock data
81 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
JANX Janux Therapeutics Inc | 808.48 k | 16.71 k shares | 4.17 | Common equity | Long | USA |
MGNX Macrogenics Inc | 635.02 k | 35.40 k shares | 3.27 | Common equity | Long | USA |
MRSN Mersana Therapeutics Inc | 631.93 k | 116.16 k shares | 3.26 | Common equity | Long | USA |
YMAB Y-Mabs Therapeutics Inc | 552.02 k | 33.06 k shares | 2.85 | Common equity | Long | USA |
FATE Fate Therapeutics Inc | 531.59 k | 74.98 k shares | 2.74 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 497.95 k | 31.30 k shares | 2.57 | Common equity | Long | USA |
AMAM Ambrx Biopharma Inc. | 493.42 k | 17.66 k shares | 2.54 | Common equity | Long | USA |
IBRX ImmunityBio Inc | 433.46 k | 91.64 k shares | 2.24 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc | 400.47 k | 88.21 k shares | 2.07 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 391.29 k | 13.27 k shares | 2.02 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 369.70 k | 8.66 k shares | 1.91 | Common equity | Long | USA |
MOR Morphosys AG | 361.06 k | 20.52 k shares | 1.86 | Common equity | Long | Germany |
KURA Kura Oncology Inc | 351.57 k | 16.68 k shares | 1.81 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 344.84 k | 57.47 k shares | 1.78 | Common equity | Long | UK |
ACLX Arcellx Inc | 328.31 k | 4.99 k shares | 1.69 | Common equity | Long | USA |
MRUS Merus N.V | 328.11 k | 6.77 k shares | 1.69 | Common equity | Long | Netherlands |
ARVN Arvinas Inc | 310.78 k | 6.76 k shares | 1.60 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 308.42 k | 6.26 k shares | 1.59 | Common equity | Long | USA |
CGEM Cullinan Therapeutics Inc | 305.88 k | 16.56 k shares | 1.58 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 304.69 k | 3.26 k shares | 1.57 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 292.99 k | 3.48 k shares | 1.51 | Common equity | Long | USA |
ZYME Zymeworks Inc. | 291.33 k | 24.26 k shares | 1.50 | Common equity | Long | USA |
INBX Inhibrx Inc | 288.90 k | 7.89 k shares | 1.49 | Common equity | Long | USA |
LYEL Lyell Immunopharma Inc | 285.00 k | 97.60 k shares | 1.47 | Common equity | Long | USA |
IGMS IGM Biosciences Inc | 283.04 k | 22.41 k shares | 1.46 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 259.06 k | 19.25 k shares | 1.34 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 252.73 k | 5.65 k shares | 1.30 | Common equity | Long | USA |
NUVB Nuvation Bio Inc - Ordinary Shares | 237.28 k | 126.89 k shares | 1.22 | Common equity | Long | USA |
NRIX Nurix Therapeutics Inc | 229.92 k | 18.62 k shares | 1.19 | Common equity | Long | USA |
ACET Adicet Bio Inc | 226.69 k | 96.46 k shares | 1.17 | Common equity | Long | USA |
TYRA Tyra Biosciences Inc | 224.13 k | 11.21 k shares | 1.16 | Common equity | Long | USA |
PRLD Prelude Therapeutics Inc | 223.05 k | 51.87 k shares | 1.15 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 222.70 k | 9.50 k shares | 1.15 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 222.65 k | 28.15 k shares | 1.15 | Common equity | Long | USA |
TNGX Tango Therapeutics Inc | 215.73 k | 19.38 k shares | 1.11 | Common equity | Long | USA |
EXAI Exscientia Plc | 213.41 k | 32.09 k shares | 1.10 | Common equity | Long | UK |
TSVT 2seventy bio Inc | 211.79 k | 40.73 k shares | 1.09 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 210.00 k | 3.12 k shares | 1.08 | Common equity | Long | UK |
ALLO Allogene Therapeutics Inc | 208.20 k | 42.40 k shares | 1.07 | Common equity | Long | USA |
STRO Sutro Biopharma Inc | 207.14 k | 42.19 k shares | 1.07 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 205.12 k | 12.29 k shares | 1.06 | Common equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 198.56 k | 7.91 k shares | 1.02 | Common equity | Long | UK |
DAWN Day One Biopharmaceuticals Inc | 198.23 k | 11.85 k shares | 1.02 | Common equity | Long | USA |
MRK Merck & Co Inc | 196.32 k | 1.54 k shares | 1.01 | Common equity | Long | USA |
FHTX Foghorn Therapeutics Inc | 195.86 k | 25.34 k shares | 1.01 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 192.25 k | 199.00 shares | 0.99 | Common equity | Long | USA |
NGM Ngm Biopharmaceuticals Inc | 191.39 k | 125.92 k shares | 0.99 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 190.42 k | 10.88 k shares | 0.98 | Common equity | Long | USA |
XNCR Xencor Inc | 182.96 k | 7.97 k shares | 0.94 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 176.38 k | 17.60 k shares | 0.91 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics Inc | 173.73 k | 27.45 k shares | 0.90 | Common equity | Long | USA |
PGEN Precigen Inc | 170.49 k | 110.71 k shares | 0.88 | Common equity | Long | USA |
HCM HUTCHMED (China) Limited | 169.41 k | 11.21 k shares | 0.87 | Common equity | Long | Hong Kong |
IMTX Immatics N.V | 169.27 k | 13.53 k shares | 0.87 | Common equity | Long | Germany |
EXEL Exelixis Inc | 165.61 k | 7.56 k shares | 0.85 | Common equity | Long | USA |
ELVN Enliven Therapeutics Inc | 163.61 k | 10.25 k shares | 0.84 | Common equity | Long | USA |
VOR Vor Biopharma Inc | 162.83 k | 70.79 k shares | 0.84 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 161.92 k | 2.49 k shares | 0.84 | Common equity | Long | USA |
AURA Aura Biosciences Inc | 158.99 k | 17.53 k shares | 0.82 | Common equity | Long | USA |
KPTI Karyopharm Therapeutics Inc | 158.14 k | 136.32 k shares | 0.82 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 153.38 k | 8.02 k shares | 0.79 | Common equity | Long | USA |
ERAS Erasca Inc | 152.16 k | 63.93 k shares | 0.78 | Common equity | Long | USA |
GERN Geron Corp. | 149.28 k | 74.64 k shares | 0.77 | Common equity | Long | USA |
IPHA Innate Pharma | 145.09 k | 55.17 k shares | 0.75 | Common equity | Long | France |
ITOS ITeos Therapeutics Inc | 143.37 k | 13.39 k shares | 0.74 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Co. | 141.80 k | 2.79 k shares | 0.73 | Common equity | Long | USA |
CMPX Compass Therapeutics Inc | 137.85 k | 77.44 k shares | 0.71 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares | 129.91 k | 85.47 k shares | 0.67 | Common equity | Long | USA |
BNTX BioNTech SE | 129.70 k | 1.46 k shares | 0.67 | Common equity | Long | Germany |
SDGR Schrodinger Inc | 127.12 k | 4.99 k shares | 0.66 | Common equity | Long | USA |
IMRX Immuneering Corp - Ordinary Shares | 127.04 k | 20.49 k shares | 0.66 | Common equity | Long | USA |
GMAB Genmab | 120.55 k | 4.34 k shares | 0.62 | Common equity | Long | Denmark |
RPTX Repare Therapeutics Inc | 111.08 k | 15.98 k shares | 0.57 | Common equity | Long | Canada |
ZNTL Zentalis Pharmaceuticals Inc | 105.04 k | 7.05 k shares | 0.54 | Common equity | Long | USA |
AGEN Agenus Inc | 84.36 k | 125.92 k shares | 0.44 | Common equity | Long | USA |
REPL Replimune Group Inc | 79.10 k | 9.22 k shares | 0.41 | Common equity | Long | USA |
ACRV Acrivon Therapeutics Inc | 75.98 k | 15.63 k shares | 0.39 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 72.49 k | 8.46 k shares | 0.37 | Common equity | Long | USA |
First American Government Obligations Fund | 54.27 k | 54.27 k shares | 0.28 | Short-term investment vehicle | Long | USA |
GNLX Genelux Corp | 53.25 k | 7.29 k shares | 0.27 | Common equity | Long | USA |
Apollomics Inc
|
31.44 k | 41.97 k shares | 0.16 | Common equity | Long | USA |